Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Genetic Testing × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Breast Neoplasms 12 Prostatic Neoplasms 9 Colorectal Neoplasms 6 Endometrial Neoplasms 5 Ovarian Neoplasms 4 Colonic Neoplasms 4 Rectal Neoplasms 3 Pancreatic Neoplasms 3 Colorectal Neoplasms, Hereditary Nonpolyposis 3 Brain Neoplasms 3 Wilms Tumor 2 Urogenital Neoplasms 2 Neoplastic Syndromes, Hereditary 2 Neoplasms, Unknown Primary 2 Neoplasm Metastasis 2 Leukemia, Myeloid, Acute 2 Kidney Neoplasms 2 Hereditary Breast and Ovarian Cancer Syndrome 2 Hematologic Neoplasms 2 Head and Neck Neoplasms 2 Glioma 2 Women Age 35+ Qualifies if >15% Lifetime Risk of Breast Cancer as Defined by IBIS Version 8 1 Unspecified Childhood Solid Tumor, Protocol Specific 1 Tuberous Sclerosis 1 Thyroid Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Spinal Cord Neoplasms 1 Sarcoma 1 Primary Ovarian Insufficiency 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

pembrolizumab 150 Gemcitabine 135 Paclitaxel 128 Carboplatin 118 Bevacizumab 110 Surveys and Questionnaires 97 Docetaxel 95 Cisplatin 94 Cyclophosphamide 93 Exercise 89 Blood Specimen Collection 85 Nivolumab 82 Fluorouracil 75 Capecitabine 73 Dexamethasone 70 Radiotherapy 69 Irinotecan 62 Standard of Care 59 Pemetrexed 59 Oxaliplatin 57 Leucovorin 54 Drug Therapy 54 Cetuximab 48 Erlotinib Hydrochloride 46 atezolizumab 44 Sorafenib 44 Interviews as Topic 41 Doxorubicin 41 Ipilimumab 38 Magnetic Resonance Spectroscopy 37

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06008392 2025-10-10

INTERCEPTioN

Mayo Clinic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡